<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36295814</PMID><DateRevised><Year>2022</Year><Month>10</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2218-1989</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>10</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>27</Day></PubDate></JournalIssue><Title>Metabolites</Title><ISOAbbreviation>Metabolites</ISOAbbreviation></Journal><ArticleTitle>Gut Microbiota Dynamics in Relation to Long-COVID-19 Syndrome: Role of Probiotics to Combat Psychiatric Complications.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">912</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/metabo12100912</ELocationID><Abstract><AbstractText>Increasing numbers of patients who recover from COVID-19 report lasting symptoms, such as fatigue, muscle weakness, dementia, and insomnia, known collectively as post-acute COVID syndrome or long COVID. These lasting symptoms have been examined in different studies and found to influence multiple organs, sometimes resulting in life-threating conditions. In this review, these symptoms are discussed in connection to the COVID-19 and long-COVID-19 immune changes, highlighting oral and psychiatric health, as this work focuses on the gut microbiota's link to long-COVID-19 manifestations in the liver, heart, kidney, brain, and spleen. A model of this is presented to show the biological and clinical implications of gut microbiota in SARS-CoV-2 infection and how they could possibly affect the therapeutic aspects of the disease. Probiotics can support the body's systems in fighting viral infections. This review focuses on current knowledge about the use of probiotics as adjuvant therapies for COVID-19 patients that might help to prevent long-COVID-19 complications.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alenazy</LastName><ForeName>Maha F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Department of Physiology, College of Medicine, King Saud University, Riyadh 11682, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aljohar</LastName><ForeName>Haya I</ForeName><Initials>HI</Initials><Identifier Source="ORCID">0000-0001-8873-1040</Identifier><AffiliationInfo><Affiliation>Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11495, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alruwaili</LastName><ForeName>Ashwag R</ForeName><Initials>AR</Initials><Identifier Source="ORCID">0000-0003-1495-6882</Identifier><AffiliationInfo><Affiliation>Department of Radiological Sciences, College of Applied Medical Science, King Saud University, Riyadh 11595, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daghestani</LastName><ForeName>Maha H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Zoology, College of Science, King Saud University, Riyadh 11495, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alonazi</LastName><ForeName>Mona A</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0002-9430-7980</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry, College of Science, King Saud University, Riyadh 11495, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Labban</LastName><ForeName>Ranyah S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>General Administration of Nutrition, Ministry of Health, Riyadh 11595, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Ansary</LastName><ForeName>Afaf K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Senior Scientist, Central Research Laboratory, Female Campus, King Saud University, Riyadh 11595, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balto</LastName><ForeName>Hanan A</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Department of Restorative Dental Sciences, College of Dentistry, King Saud University, P.O. Box 62645, Riyadh 11595, Saudi Arabia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>RSP2022R179</GrantID><Agency>King Saud University, Riyadh, Saudi Arabia</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Metabolites</MedlineTA><NlmUniqueID>101578790</NlmUniqueID><ISSNLinking>2218-1989</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">gut microbiota</Keyword><Keyword MajorTopicYN="N">gut&#x2013;organ axis</Keyword><Keyword MajorTopicYN="N">long COVID-19</Keyword><Keyword MajorTopicYN="N">probiotics</Keyword><Keyword MajorTopicYN="N">psychiatric disorders</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>27</Day><Hour>1</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36295814</ArticleId><ArticleId IdType="pmc">PMC9611210</ArticleId><ArticleId IdType="doi">10.3390/metabo12100912</ArticleId><ArticleId IdType="pii">metabo12100912</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dong E., Du H., Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect. Dis. 2020;20:533&#x2013;534. doi: 10.1016/S1473-3099(20)30120-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30120-1</ArticleId><ArticleId IdType="pmc">PMC7159018</ArticleId><ArticleId IdType="pubmed">32087114</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A., Madhavan M.V., Sehgal K., Nair N., Mahajan S., Sehrawat T.S., Bikdeli B., Ahluwalia N., Ausiello J.C., Wan E.Y., et al. Extrapulmonary manifestations of COVID-19. Nat. Med. 2020;26:1017&#x2013;1032. doi: 10.1038/s41591-020-0968-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Persistent symptoms in patients after Acute COVID-19. JAMA. 2020;324:603&#x2013;6052020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Wang Y., Li X., Ren L., Gu X. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397:220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>McElvaney O.J., McEvoy N.L., McElvaney O.F., Carroll T.P., Murphy M.P., Dunlea D.M., N&#xed; Choile&#xe1;in O., Clarke J., O&#x2019;Connor E., Hogan G., et al. Characterization of the inflammatory response to severe COVID-19 Illness. Am. J. Respir. Crit. Care Med. 2020;202:812&#x2013;821. doi: 10.1164/rccm.202005-1583OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202005-1583OC</ArticleId><ArticleId IdType="pmc">PMC7491404</ArticleId><ArticleId IdType="pubmed">32584597</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang N., Li D., Wang X., Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J. Thromb. Haemost. 2020;18:844&#x2013;847. doi: 10.1111/jth.14768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14768</ArticleId><ArticleId IdType="pmc">PMC7166509</ArticleId><ArticleId IdType="pubmed">32073213</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Mak J.W.Y., Su Q., Yeoh Y.K., Lui G.C.Y., Ng S.S.S., Zhang F., Li A.Y.L., Lu W., Hui D.S., et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022;71:544&#x2013;552. doi: 10.1136/gutjnl-2021-325989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Gu S., Chen Y., Lu H., Shi D., Guo J., Wu W.R., Yang Y., Li Y., Xu K.J., et al. Six-month follow-up of gut microbiota richness in patients with COVID-19. Gut. 2022;71:222. doi: 10.1136/gutjnl-2021-324090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-324090</ArticleId><ArticleId IdType="pmc">PMC8666823</ArticleId><ArticleId IdType="pubmed">33833065</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng S.C., Tilg H. COVID-19 and the gastrointestinal tract: More than meets the eye. Gut. 2020;69:973. doi: 10.1136/gutjnl-2020-321195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-321195</ArticleId><ArticleId IdType="pmc">PMC7211058</ArticleId><ArticleId IdType="pubmed">32273292</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T., Zhang F., Lui G.C., Yeoh Y.K., Li A.Y., Zhan H., Wan Y., Chung A.C.K., Cheung C.P., Chen N., et al. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology. 2020;159:944&#x2013;955.e8. doi: 10.1053/j.gastro.2020.05.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.048</ArticleId><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T., Liu Q., Zhang F., Lui G.C.Y., Tso E.Y., Yeoh Y.K., Chen Z., Boon S.S., Chan F.K.L., Chan P.K.S., et al. Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19. Gut. 2021;70:276&#x2013;284. doi: 10.1136/gutjnl-2020-322294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-322294</ArticleId><ArticleId IdType="pmc">PMC7385744</ArticleId><ArticleId IdType="pubmed">32690600</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh Y.K., Zuo T., Lui G.C., Zhang F., Liu Q., Li A.Y., Chung A.C., Cheung C.P., Tso E.Y., Fung K.S., et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70:698&#x2013;706. doi: 10.1136/gutjnl-2020-323020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323020</ArticleId><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Geva-Zatorsky N., Sefik E., Kua L., Pasman L., Tan T.G., Ortiz-Lopez A., Yanortsang T.B., Yang L., Jupp R., Mathis D., et al. Mining the human gut microbiota for immunomodulatory organisms. Cell. 2017;168:928&#x2013;943. doi: 10.1016/j.cell.2017.01.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.01.022</ArticleId><ArticleId IdType="pmc">PMC7774263</ArticleId><ArticleId IdType="pubmed">28215708</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly D., Campbell J.I., King T.P., Grant G., Jansson E.A., Coutts A.G., Pettersson S., Conway S. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shutting of PPAR-&#x3b3; and ReIA. Nat. Immunol. 2004;5:104&#x2013;112. doi: 10.1038/ni1018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1018</ArticleId><ArticleId IdType="pubmed">14691478</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrzosek L., Miquel S., Noordine M.L., Bouet S., Chevalier-Curt M.J., Robert V., Philippe C., Bridonneau C., Cherbuy C., Robbe-Masselot C., et al. Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent. BMC Biol. 2013;11:61. doi: 10.1186/1741-7007-11-61.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1741-7007-11-61</ArticleId><ArticleId IdType="pmc">PMC3673873</ArticleId><ArticleId IdType="pubmed">23692866</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamel A.H.M., Basuoni A., Salem Z.A., AbuBakr N. The impact of oral health status on COVID-19 severity, recovery period and C-reactive protein values. Br. Dent. J. 2021 doi: 10.1038/s41415-021-2656-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41415-021-2656-1</ArticleId><ArticleId IdType="pmc">PMC7904030</ArticleId><ArticleId IdType="pubmed">33627848</ArticleId></ArticleIdList></Reference><Reference><Citation>Franziska B. Good oral health may prevent severe COVID-19 progression. Ger. Soc. Dent. Oral Med. GSDOM. 2020;22:6527.</Citation></Reference><Reference><Citation>Buunk-Werkhoven Y.A.B., Reyerse E. What is the impact of oral (Public) health promotion, and of interventions for oral (self) care awareness raising and behavior change? J. Dent. Oral Disord. Ther. 2020;8:1&#x2013;4. doi: 10.15226/jdodt.2020.001114.</Citation><ArticleIdList><ArticleId IdType="doi">10.15226/jdodt.2020.001114</ArticleId></ArticleIdList></Reference><Reference><Citation>France K., Glick M. Long COVID and oral health care considerations. J. Am. Dent. Assoc. 2022;153:167&#x2013;174. doi: 10.1016/j.adaj.2021.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.adaj.2021.08.007</ArticleId><ArticleId IdType="pmc">PMC8553648</ArticleId><ArticleId IdType="pubmed">34756590</ArticleId></ArticleIdList></Reference><Reference><Citation>Gherlone E.F., Polizzi E., Tet&#xe8; G., De Lorenzo R., Magnaghi C., Rovere Querini P., Ciceri F. Frequent and persistent salivary gland ectasia and oral disease after COVID-19. J. Dent. Res. 2021;100:464&#x2013;471. doi: 10.1177/0022034521997112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0022034521997112</ArticleId><ArticleId IdType="pmc">PMC7930603</ArticleId><ArticleId IdType="pubmed">33655804</ArticleId></ArticleIdList></Reference><Reference><Citation>Neto C.L.D.M.M., Bannwart L.C., de Melo Moreno A.L., Goiato M.C. SARS-CoV-2 and Dentistry-Review. Eur. J. Dent. 2020;14:S130&#x2013;S139. doi: 10.1055/s-0040-1716438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1716438</ArticleId><ArticleId IdType="pmc">PMC7775231</ArticleId><ArticleId IdType="pubmed">32932534</ArticleId></ArticleIdList></Reference><Reference><Citation>Paradowska-Stolarz A.M. Oral manifestations of COVID-19: Brief review. Dent. Med. Probl. 2021;58:123&#x2013;126. doi: 10.17219/dmp/131989.</Citation><ArticleIdList><ArticleId IdType="doi">10.17219/dmp/131989</ArticleId><ArticleId IdType="pubmed">33590976</ArticleId></ArticleIdList></Reference><Reference><Citation>Zangrillo A., Beretta L., Scandroglio A.M., Monti G., Fominskiy E., Colombo S., Morselli F., Belletti A., Silvani P., Crivellari M., et al. Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy. Crit. Care Resusc. 2020;22:200&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10692521</ArticleId><ArticleId IdType="pubmed">32900326</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C., Chen X., Cai Y., Zhou X., Xu S., Huan H., Zhang L., Zhou X., Du C., Zhang Y., et al. Risk factors associated with acute respiratory distress syndrome and death in patients with Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern. Med. 2020;180:934&#x2013;943. doi: 10.1001/jamainternmed.2020.0994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.0994</ArticleId><ArticleId IdType="pmc">PMC7070509</ArticleId><ArticleId IdType="pubmed">32167524</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira L.A., Salzano G., Deiana G., de Riu G. Anosmia and Ageusia: Common Findings in COVID-19 Patients. Laryngoscope. 2020;130:1787. doi: 10.1002/lary.28692.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.28692</ArticleId><ArticleId IdType="pmc">PMC7228304</ArticleId><ArticleId IdType="pubmed">32237238</ArticleId></ArticleIdList></Reference><Reference><Citation>Isho B., Abe K.T., Zuo M., Jamal A.J., Rathod B., Wang J.H., Li Z., Chao G., Rojas O.L., Bang Y.M., et al. Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients. Sci. Immunol. 2020;5:eabe5511. doi: 10.1126/sciimmunol.abe5511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abe5511</ArticleId><ArticleId IdType="pmc">PMC8050884</ArticleId><ArticleId IdType="pubmed">33033173</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisanic N., Randad P.R., Kruczynski K., Manabe Y.C., Thomas D.L., Pekosz A., Klein S.L., Betenbaugh M.J., Clarke W.A., Laeyendecker O., et al. COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in saliva. J. Clin. Microbiol. 2020;59:e02204-20. doi: 10.1128/JCM.02204-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.02204-20</ArticleId><ArticleId IdType="pmc">PMC7771435</ArticleId><ArticleId IdType="pubmed">33067270</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji D., Qin E., Xu J., Zhang D., Cheng G., Wang Y., Lau G. Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study. J. Hepatol. 2020;73:451&#x2013;453. doi: 10.1016/j.jhep.2020.03.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2020.03.044</ArticleId><ArticleId IdType="pmc">PMC7141624</ArticleId><ArticleId IdType="pubmed">32278005</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y.J., Zheng K.I., Wang X.B., Yan H.D., Sun Q.F., Pan K.H., Wang T.Y., Ma H.L., Chen Y.P., George J., et al. Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis. J. Hepatol. 2020;73:719&#x2013;721. doi: 10.1016/j.jhep.2020.04.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2020.04.027</ArticleId><ArticleId IdType="pmc">PMC7195041</ArticleId><ArticleId IdType="pubmed">32348790</ArticleId></ArticleIdList></Reference><Reference><Citation>Assante G., Williams R., Youngson N.A. Is the increased risk for MAFLD patients to develop severe COVID-19 linked to perturbation of the gut-liver axis? J. Hepatol. 2021;74:487&#x2013;488. doi: 10.1016/j.jhep.2020.05.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2020.05.051</ArticleId><ArticleId IdType="pmc">PMC7305888</ArticleId><ArticleId IdType="pubmed">32574578</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan L., Mu M.I., Yang P., Sun Y., Wang R., Yan J., Li P., Hu B., Wang J., Hu C., et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: A descriptive, cross-sectional, multicenter study. Am. J. Gastroenterol. 2020;115:766&#x2013;773. doi: 10.14309/ajg.0000000000000620.</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ajg.0000000000000620</ArticleId><ArticleId IdType="pmc">PMC7172492</ArticleId><ArticleId IdType="pubmed">32287140</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao F., Tang M., Zheng X., Liu Y., Li X., Shan H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020;158:1831&#x2013;1833.e3. doi: 10.1053/j.gastro.2020.02.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.02.055</ArticleId><ArticleId IdType="pmc">PMC7130181</ArticleId><ArticleId IdType="pubmed">32142773</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., Kr&#xfc;ger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A., et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271&#x2013;280.e8. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertram S., Heurich A., Lavender H., Gierer S., Danisch S., Perin P., Lucas J.M., Nelson P.S., P&#xf6;hlmann S., Soilleux E.J. Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts. PLoS ONE. 2012;7:e35876. doi: 10.1371/journal.pone.0035876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0035876</ArticleId><ArticleId IdType="pmc">PMC3340400</ArticleId><ArticleId IdType="pubmed">22558251</ArticleId></ArticleIdList></Reference><Reference><Citation>Tr&#xf8;seid M., Andersen G.&#xd8;., Broch K., Hov J.R. The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions. EBioMedicine. 2020;52:102649. doi: 10.1016/j.ebiom.2020.102649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.102649</ArticleId><ArticleId IdType="pmc">PMC7016372</ArticleId><ArticleId IdType="pubmed">32062353</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts L.M., Buford T.W. Lipopolysaccharide binding protein is associated with CVD risk in older adults. Aging Clin. Exp. Res. 2021;33:1651&#x2013;1658. doi: 10.1007/s40520-020-01684-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-020-01684-z</ArticleId><ArticleId IdType="pmc">PMC7937758</ArticleId><ArticleId IdType="pubmed">32895891</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y., Wang G., Cai X.P., Deng J.W., Zheng L., Zhu H.H., Yang B., Zheng M., Chen Z. An overview of COVID-19. J. Zhejiang Univ. Sci. B. 2020;21:343&#x2013;360. doi: 10.1631/jzus.B2000083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1631/jzus.B2000083</ArticleId><ArticleId IdType="pmc">PMC7205601</ArticleId><ArticleId IdType="pubmed">32425000</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y.C., Chen C.S., Chan Y.J. The outbreak of COVID-19: An overview. J. Chin. Med. Assoc. 2020;83:217&#x2013;220. doi: 10.1097/JCMA.0000000000000270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JCMA.0000000000000270</ArticleId><ArticleId IdType="pmc">PMC7153464</ArticleId><ArticleId IdType="pubmed">32134861</ArticleId></ArticleIdList></Reference><Reference><Citation>Inciardi R.M., Lupi L., Zaccone G., Italia L., Raffo M., Tomasoni D., Cani D.S., Cerini M., Farina D., Gavazzim E. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5:819&#x2013;824. doi: 10.1001/jamacardio.2020.1096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1096</ArticleId><ArticleId IdType="pmc">PMC7364333</ArticleId><ArticleId IdType="pubmed">32219357</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarfraz Z., Sarfraz A., Barrios A., Garimella R., Dominari A., Kc M., Pandav K., Pantoja J.C., Retnakumar V., Cherrez-Ojeda I. Cardio-Pulmonary sequelae in recovered COVID-19 patients: Considerations for primary care. J. Prim. Care Community Health. 2021;12:21501327211023726. doi: 10.1177/21501327211023726.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/21501327211023726</ArticleId><ArticleId IdType="pmc">PMC8188976</ArticleId><ArticleId IdType="pubmed">34096390</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanini A.M., Fidelis T.O., Penna G.M., Pessanha G.R.G., Marques R.A.G., Oliveira D.C.D. Tomographic identification and evaluation of pulmonary involvement due to SARS-CoV-2 infection using artificial intelligence and image segmentation technique. In: Rojas I., Castillo-Secilla D., editors. Bioengineering and Biomedical Signal and Image Processing. Springer International Publishing; Berlin/Heidelberg, Germany: 2021. pp. 405&#x2013;416.</Citation></Reference><Reference><Citation>Gheblawi M., Wang K., Viveiros A., Nguyen Q., Zhong J.C., Turner A.J., Raizada M.K., Grant M.B., Oudit G.Y. Angiotensin-Converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: Celebrating the 20th anniversary of the discovery of ACE2. Circ. Res. 2020;126:1456&#x2013;1474. doi: 10.1161/CIRCRESAHA.120.317015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317015</ArticleId><ArticleId IdType="pmc">PMC7188049</ArticleId><ArticleId IdType="pubmed">32264791</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdecchia P., Angeli F., Reboldi G. Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and coronavirus. Cell. 2020;38:1190&#x2013;1191. doi: 10.1097/HJH.0000000000002469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HJH.0000000000002469</ArticleId><ArticleId IdType="pmc">PMC7236844</ArticleId><ArticleId IdType="pubmed">32371811</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoel H., Heggelund L., Reikvam D.H., Stiksrud B., Ueland T., Michelsen A.E., Otterdal K., Muller K.E., Lind A., Muller F., et al. Elevated markers of gut leakage and inflammasome activation in COVID-19 patients with cardiac involvement. J. Intern. Med. 2021;289:523&#x2013;531. doi: 10.1111/joim.13178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13178</ArticleId><ArticleId IdType="pmc">PMC7536991</ArticleId><ArticleId IdType="pubmed">32976665</ArticleId></ArticleIdList></Reference><Reference><Citation>Mielcarek C., Romond P.C., Romond M.B., Bezirtzoglou E. Modulation of bacterial translocation in mice mediated through lactose and human milk oligosaccharides. Anaerobe. 2011;17:361&#x2013;366. doi: 10.1016/j.anaerobe.2011.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anaerobe.2011.09.002</ArticleId><ArticleId IdType="pubmed">21939778</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebbers J.-O., Laissue J.-A. Bacterial Translocation in the Normal Human Appendix Parallels the Development of the Local Immune System. Ann. N. Y. Acad. Sci. 2004;1029:337&#x2013;343. doi: 10.1196/annals.1309.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1309.015</ArticleId><ArticleId IdType="pubmed">15681775</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobby G.P., Karaduta O., Dusio G.F., Singh M., Zybailov B.L., Arthur J.M. Chronic kidney disease and the gut microbiome. Am. J. Physiol. Ren. Physiol. 2019;316:F1211&#x2013;F1217. doi: 10.1152/ajprenal.00298.2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.00298.2018</ArticleId><ArticleId IdType="pmc">PMC6620595</ArticleId><ArticleId IdType="pubmed">30864840</ArticleId></ArticleIdList></Reference><Reference><Citation>Flythe J.E., Assimon M.M., Tugman M.J., Chang E.H., Gupta S., Shah J., Sosa M.A., Renaghan A.D., Melamed M.L., Wilson F.P., et al. Characteristics and outcomes of individuals with pre-existing kidney disease and covid-19 admitted to intensive care units in the United States. Am. J. Kidney Dis. 2021;77:190&#x2013;203.e1. doi: 10.1053/j.ajkd.2020.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2020.09.003</ArticleId><ArticleId IdType="pmc">PMC7501875</ArticleId><ArticleId IdType="pubmed">32961244</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva M.A., da Silva A.R.P.A., do Amaral M.A., Fragas M.G., C&#xe2;mara N.O.S. Metabolic Alterations in SARS-CoV-2 Infection and Its Implication in Kidney Dysfunction. Front. Physiol. 2021;12:624698. doi: 10.3389/fphys.2021.624698.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2021.624698</ArticleId><ArticleId IdType="pmc">PMC7947848</ArticleId><ArticleId IdType="pubmed">33716771</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson F.A., Mihealsick R.P., Wagener B.M., Hanna P., Poston M.D., Efimov I.R., Shivkumar K., Hoover D.B. Role of angiotensin-converting enzyme 2 and pericytes in cardiac complications of COVID-19 infection. Am. J. Physiology. Heart Circ. Physiol. 2020;319:H1059&#x2013;H1068. doi: 10.1152/ajpheart.00681.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00681.2020</ArticleId><ArticleId IdType="pmc">PMC7789968</ArticleId><ArticleId IdType="pubmed">33036546</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunutsor S.K., Laukkanen J.A. Renal complications in COVID-19: A systematic review and meta-analysis. Ann. Med. 2020;52:345&#x2013;353. doi: 10.1080/07853890.2020.1790643.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2020.1790643</ArticleId><ArticleId IdType="pmc">PMC7877945</ArticleId><ArticleId IdType="pubmed">32643418</ArticleId></ArticleIdList></Reference><Reference><Citation>Voorend C.G.N., Van Oevelen M., Nieberg M., Meuleman Y., Franssen C.F.M., Joosten H., Berkhout-Byrne N.C., Abrahams A.C., Mooijaart S.P., Bos W.J.W., et al. Impact of the COVID-19 pandemic on symptoms of anxiety and depression and health-related quality of life in older patients with chronic kidney disease. BMC Geriatr. 2021;21:650. doi: 10.1186/s12877-021-02593-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-021-02593-0</ArticleId><ArticleId IdType="pmc">PMC8602979</ArticleId><ArticleId IdType="pubmed">34798817</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y., Wu J., Lu J., Xu X., Long W., Yan G., Tang M., Zou L., Xu Z., Zhuo P., et al. Investigation of COVID-19-related symptoms based on factor analysis. Ann Palliat Med. 2020;9:1851&#x2013;1858. doi: 10.21037/apm-20-1113.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/apm-20-1113</ArticleId><ArticleId IdType="pubmed">32576016</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J., Kremer S., Merdji H., Clere-Jehl R., Schenck M., Kummerlen C., Collange O., Boulay C., Fafi-Kremer S., Ohanam M., et al. Neurologic Features in Severe SARS-CoV-2 Infection. New Engl. J. Med. 2020;382:2268&#x2013;2270. doi: 10.1056/NEJMc2008597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2008597</ArticleId><ArticleId IdType="pmc">PMC7179967</ArticleId><ArticleId IdType="pubmed">32294339</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards J.L., Yap Y.A., McLeod K.H., MacKay C.R., Marin&#xf5; E. Dietary metabolites and the gut microbiota: An alternative approach to control inflammatory and autoimmune diseases. Clin. Transl. Immunol. 2016;5:e82. doi: 10.1038/cti.2016.29.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cti.2016.29</ArticleId><ArticleId IdType="pmc">PMC4910123</ArticleId><ArticleId IdType="pubmed">27350881</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranganathan N., Ranganathan P., Friedman E.A., Joseph A., Delano B., Goldfarb D.S., Tam P., Rao A.V., Anteyi E., Musso C.G. Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease. Adv. Ther. 2010;27:634&#x2013;647. doi: 10.1007/s12325-010-0059-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12325-010-0059-9</ArticleId><ArticleId IdType="pubmed">20721651</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuuchi F., Hida M., Aiba Y., Koga Y., Endoh M., Kurokawa K., Sakai H. Intestinal bacteria-derived putrefactants in chronic renal failure. Clin. Exp. Nephrol. 2002;6:99&#x2013;104. doi: 10.1007/s101570200016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s101570200016</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalewajska M., Przybyci&#x144;ski J., Marchelek-My&#x15b;liwiec M., Dziedziejko V., Ciechanowski K. Gut Microbiota In Chronic Kidney Disease. Post&#x119;py Mikrobiol. Adv. Microbiol. 2019;58:237&#x2013;245. doi: 10.21307/PM-2019.58.3.237.</Citation><ArticleIdList><ArticleId IdType="doi">10.21307/PM-2019.58.3.237</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L., Jin H., Wang M., Hu Y., Chen S., He Q., Chang J., Hong C., Zhou Y., Wang D., et al. Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China. JAMA Neurol. 2020;77:683&#x2013;690. doi: 10.1001/jamaneurol.2020.1127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo J., Huang Z., Lin L., Lv J. Coronavirus disease 2019 (COVID-19) and cardiovascular disease: A viewpoint on the potential influence of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers on onset and severity of severe acute respiratory syndrome coronavirus 2 infection. J. Am. Heart Assoc. 2020;9:e016219. doi: 10.1161/JAHA.120.016219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.120.016219</ArticleId><ArticleId IdType="pmc">PMC7428639</ArticleId><ArticleId IdType="pubmed">32233755</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandemirli S.G., Dogan L., Sarikaya Z.T., Kara S., Akinci C., Kaya D., Kaya Y., Yildirim D., Tuzuner F., Yildirim M.S., et al. Brain MRI findings in patients in the intensive care unit with COVID-19 infection. Radiology. 2020;297:E232&#x2013;E235. doi: 10.1148/radiol.2020201697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020201697</ArticleId><ArticleId IdType="pmc">PMC7507997</ArticleId><ArticleId IdType="pubmed">32384020</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J., L&#xfc;tgehetmann M., Hagel C., Sperhake J.P., Schr&#xf6;der A.S., Edler C., Mushumba H., Fitzek A., Allweiss L., Dandri M., et al. Neuropathology of patients with COVID-19 in Germany: A post-mortem case series. Lancet Neurol. 2020;19:919&#x2013;929. doi: 10.1016/S1474-4422(20)30308-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30308-2</ArticleId><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Guennec L., Devianne J., Jalin L., Cao A., Galanaud D., Navarro V., Boutolleau D., Rohaut B., Weiss N., Demeret S. Orbitofrontal involvement in a neuroCOVID-19 patient. Epilepsia. 2020;61:e90&#x2013;e94. doi: 10.1111/epi.16612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/epi.16612</ArticleId><ArticleId IdType="pmc">PMC7361605</ArticleId><ArticleId IdType="pubmed">32589794</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong W., Kwan P., Zhou D., Del Felice A., Duncan J.S., Sander J.W. Acute and late neurological complications of COVID19: The quest for evidence. Brain. 2020;143:e99. doi: 10.1093/brain/awaa294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa294</ArticleId><ArticleId IdType="pmc">PMC7543247</ArticleId><ArticleId IdType="pubmed">32995833</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed M.U., Hanif M., Ali M.J., Haider M.A., Kherani D., Memon G.M., Karim A.H., Sattar A. Neurological Manifestations of COVID-19 (SARS-CoV-2): A Review. Front. Neurol. 2020;11:518. doi: 10.3389/fneur.2020.00518.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00518</ArticleId><ArticleId IdType="pmc">PMC7257377</ArticleId><ArticleId IdType="pubmed">32574248</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudroff T., Kamholz J., Fietsam A.C., Deters J.R., Bryant A.D. Post-covid-19 fatigue: Potential contributing factors. Brain Sci. 2020;10:1012. doi: 10.3390/brainsci10121012.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci10121012</ArticleId><ArticleId IdType="pmc">PMC7766297</ArticleId><ArticleId IdType="pubmed">33352638</ArticleId></ArticleIdList></Reference><Reference><Citation>Egbert A.R., Cankurtaran S., Karpiak S. Brain abnormalities in COVID-19 acute/subacute phase: A rapid systematic review. Brain Behav. Immun. 2020;89:543&#x2013;554. doi: 10.1016/j.bbi.2020.07.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.07.014</ArticleId><ArticleId IdType="pmc">PMC7366124</ArticleId><ArticleId IdType="pubmed">32682993</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohmwald K., G&#xe1;lvez N.M.S., R&#xed;os M., Kalergis A.M. Neurologic alterations due to respiratory virus infections. Front. Cell. Neurosci. 2018;12:386. doi: 10.3389/fncel.2018.00386.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2018.00386</ArticleId><ArticleId IdType="pmc">PMC6212673</ArticleId><ArticleId IdType="pubmed">30416428</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.E., Heo J.H., Kim H.O., Song S.H., Park S.S., Park T.H., Ahn J.Y., Kim M.K., Choi J.P. Neurological complications during treatment of middle east respiratory syndrome. J. Clin. Neurol. 2017;13:227&#x2013;233. doi: 10.3988/jcn.2017.13.3.227.</Citation><ArticleIdList><ArticleId IdType="doi">10.3988/jcn.2017.13.3.227</ArticleId><ArticleId IdType="pmc">PMC5532318</ArticleId><ArticleId IdType="pubmed">28748673</ArticleId></ArticleIdList></Reference><Reference><Citation>Savarin C., Bergmann C.C. Viral-induced suppression of self-reactive T cells: Lessons from neurotropic coronavirus-induced demyelination. J. Neuroimmunol. 2017;308:12&#x2013;16. doi: 10.1016/j.jneuroim.2017.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2017.01.003</ArticleId><ArticleId IdType="pmc">PMC5474352</ArticleId><ArticleId IdType="pubmed">28108025</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y., Skinner D.D., Lane T.E. Innate immune responses and viral-induced neurologic disease. J. Clin. Med. 2019;8:3. doi: 10.3390/jcm8010003.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm8010003</ArticleId><ArticleId IdType="pmc">PMC6352557</ArticleId><ArticleId IdType="pubmed">30577473</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Xu X., Chen Z., Duan J., Hashimoto K., Yang L., Cunming L., Yang C. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav. Immun. 2020;87:18&#x2013;22. doi: 10.1016/j.bbi.2020.03.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.03.031</ArticleId><ArticleId IdType="pmc">PMC7146689</ArticleId><ArticleId IdType="pubmed">32240762</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye M., Ren Y., Lv T. Encephalitis as a clinical manifestation of COVID-19. Brain Behav. Immun. 2020;88:945&#x2013;946. doi: 10.1016/j.bbi.2020.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.04.017</ArticleId><ArticleId IdType="pmc">PMC7146652</ArticleId><ArticleId IdType="pubmed">32283294</ArticleId></ArticleIdList></Reference><Reference><Citation>Toscano G., Palmerini F., Ravaglia S., Ruiz L., Invernizzi P., Cuzzoni M.G., Franciotta D., Baldanti F., Daturi R., Postorino P., et al. Guillain&#x2013;Barr&#xe9; Syndrome associated with SARS-CoV-2. New Engl. J. Med. 2020;382:2574&#x2013;2576. doi: 10.1056/NEJMc2009191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2009191</ArticleId><ArticleId IdType="pmc">PMC7182017</ArticleId><ArticleId IdType="pubmed">32302082</ArticleId></ArticleIdList></Reference><Reference><Citation>Pincherle A., J&#xf6;hr J., Pancini L., Leocani L., Dalla Vecchia L., Ryvlin P., Schiff N.D., Diserens K. Intensive Care admission and early Neuro-Rehabilitation. Lessons for COVID-19? Front. Neurol. 2020;11:880. doi: 10.3389/fneur.2020.00880.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00880</ArticleId><ArticleId IdType="pmc">PMC7477378</ArticleId><ArticleId IdType="pubmed">32982916</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin C.H., Wang C., Tang Z., Wen Y., Zhang S.W., Wang B.E. Clinical analysis of multiple organ dysfunction syndrome in patients suffering from SARS. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2004;16:646&#x2013;650.</Citation><ArticleIdList><ArticleId IdType="pubmed">15535894</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein R.S., Garber C., Howard N. Infectious immunity in the central nervous system and brain function. Nat. Immunol. 2017;18:132&#x2013;141. doi: 10.1038/ni.3656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3656</ArticleId><ArticleId IdType="pmc">PMC5815515</ArticleId><ArticleId IdType="pubmed">28092376</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanin L., Saraceno G., Panciani P.P., Renisi G., Signorini L., Migliorati K., Fontanella M.M. SARS-CoV-2 can induce brain and spine demyelinating lesions. Acta Neurochir. 2020;162:1491&#x2013;1494. doi: 10.1007/s00701-020-04374-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00701-020-04374-x</ArticleId><ArticleId IdType="pmc">PMC7197630</ArticleId><ArticleId IdType="pubmed">32367205</ArticleId></ArticleIdList></Reference><Reference><Citation>Desforges M., Le Coupanec A., Dubeau P., Bourgouin A., Lajoie L., Dub&#xe9; M., Talbot P.J. Human coronaviruses and other respiratory viruses: Underestimated opportunistic pathogens of the central nervous system? Viruses. 2019;12:14. doi: 10.3390/v12010014.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12010014</ArticleId><ArticleId IdType="pmc">PMC7020001</ArticleId><ArticleId IdType="pubmed">31861926</ArticleId></ArticleIdList></Reference><Reference><Citation>Coolen T., Lolli V., Sadeghi N., Rovai A., Trotta N., Taccone F.S., Creteur J., Henrard S., Goffard J.C., Dewitte O., et al. Early postmortem brain MRI findings in COVID-19 non-survivors. Neurology. 2020;95:e2016&#x2013;e2027. doi: 10.1212/WNL.0000000000010116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010116</ArticleId><ArticleId IdType="pubmed">32546654</ArticleId></ArticleIdList></Reference><Reference><Citation>Poyiadji N., Shahin G., Noujaim D., Stone M., Patel S.C., Griffith B. COVID-19&#x2013;associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features. Cureus. 2020;296:E119&#x2013;E120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7233386</ArticleId><ArticleId IdType="pubmed">32228363</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S., Barnett J., Brill S.E., Brown J.S., Denneny E.K., Hare S.S., Heightman M., Hillman T.E., Jacob J., Jarvis H., et al. Long-COVID&#x2019;: A cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76:396&#x2013;398. doi: 10.1136/thoraxjnl-2020-215818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza M.G., De Lorenzo R., Conte C., Poletti S., Vai B., Bollettini I., Melloni E.M.T., Furlan R., Ciceri F., Rovere-Querini P., et al. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav. Immun. 2020;89:594&#x2013;600. doi: 10.1016/j.bbi.2020.07.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.07.037</ArticleId><ArticleId IdType="pmc">PMC7390748</ArticleId><ArticleId IdType="pubmed">32738287</ArticleId></ArticleIdList></Reference><Reference><Citation>Bottemanne H., Delaigue F., Lemogne C. SARS-CoV-2 Psychiatric Sequelae: An Urgent Need of Prevention. Front. Psychiatry. 2021;2:1479. doi: 10.3389/fpsyt.2021.738696.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.738696</ArticleId><ArticleId IdType="pmc">PMC8458863</ArticleId><ArticleId IdType="pubmed">34566731</ArticleId></ArticleIdList></Reference><Reference><Citation>Grover S., Kumar V., Chakrabarti S., Hollikatti P., Singh P., Tyagi S., Kulhara P., Avasthi A. Prevalence and Type of Functional Somatic Complaints in Patients with First-episode Depression. East Asian Arch Psychiatry. East Asian Arch. Psychiatry. 2012;22:146&#x2013;153.</Citation><ArticleIdList><ArticleId IdType="pubmed">23271583</ArticleId></ArticleIdList></Reference><Reference><Citation>Perna G., Caldirola D. COVID-19 and panic disorder: Clinical considerations for the most physical of mental disorders. Braz. J. Psychiatry. 2021;43:110&#x2013;111. doi: 10.1590/1516-4446-2020-1235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1516-4446-2020-1235</ArticleId><ArticleId IdType="pmc">PMC7861169</ArticleId><ArticleId IdType="pubmed">32756807</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezzat M.M., Elsherif A.A. Prevalence of Fatigue in Patients Post COVID-19. Eur. J. Mol. Clin. Med. 2021;08:1330&#x2013;1340.</Citation></Reference><Reference><Citation>Katafuchi T., Kondo T., Take S., Yoshimura M. Brain Cytokines and the 5-HT System during Poly I:C-Induced Fatigue. Ann. N. Y. Acad. Sci. 2006;1088:230&#x2013;237. doi: 10.1196/annals.1366.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1366.020</ArticleId><ArticleId IdType="pubmed">17192569</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa L.H.A., Santos B.M., Branco L.G.S. Can selective serotonin reuptake inhibitors have a neuroprotective effect during COVID-19? Eur. J. Pharmacol. 2020;889:173629. doi: 10.1016/j.ejphar.2020.173629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2020.173629</ArticleId><ArticleId IdType="pmc">PMC7832208</ArticleId><ArticleId IdType="pubmed">33022271</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., Arthofer C., Wang C., McCarthy P., Lange F., Andersson J., Griffanti L., Duff E., et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604:697&#x2013;707. doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Sarraj S., Troakes C., Hanley B., Osborn M., Richardson M.P., Hotopf M., Bullmore E., Everall I. Invited Review: The spectrum of neuropathology in COVID-19. Neuropathol. Appl. Neurobiol. 2021;47:3&#x2013;16. doi: 10.1111/nan.12667.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12667</ArticleId><ArticleId IdType="pubmed">32935873</ArticleId></ArticleIdList></Reference><Reference><Citation>Donegani M.I., Miceli A., Pardini M., Bauckneht M., Chiola S., Pennone M., Marini C., Massa F., Raffa S., Ferrarazzo G., et al. Brain metabolic correlates of persistent olfactory dysfunction after SARS-CoV-2 infection. Biomedicines. 2021;9:287. doi: 10.3390/biomedicines9030287.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9030287</ArticleId><ArticleId IdType="pmc">PMC7998481</ArticleId><ArticleId IdType="pubmed">33808956</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E., Campion J.Y., Dudouet P., Kaphan E., Bregeon F., Tissot-Dupont H., Guis S., Barthelemy F., Habert P., Ceccaldi M., et al. 18F-FDG brain PET hypometabolism in patients with long COVID. Eur. J. Nucl. Med. Mol. Imaging. 2021;48:2823&#x2013;2833. doi: 10.1007/s00259-021-05215-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05215-4</ArticleId><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosp J.A., Dressing A., Blazhenets G., Bormann T., Rau A., Schwabenland M., Thurow J., Wagner D., Waller C., Niesen W.D., et al. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain. 2021;144:1263&#x2013;1276. doi: 10.1093/brain/awab009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab009</ArticleId><ArticleId IdType="pmc">PMC8083602</ArticleId><ArticleId IdType="pubmed">33822001</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosconi L. Brain glucose metabolism in the early and specific diagnosis of Alzheimer&#x2019;s disease: FDG-PET studies in MCI and AD. Eur. J. Nucl. Med. Mol. Imaging. 2005;32:486&#x2013;510. doi: 10.1007/s00259-005-1762-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-005-1762-7</ArticleId><ArticleId IdType="pubmed">15747152</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoghi A., Ramezani M., Roozbeh M., Darazam I.A., Sahraian M.A. A case of possible atypical demyelinating event of the central nervous system following COVID-19. Mult. Scler. Relat. Disord. 2020;44:102324. doi: 10.1016/j.msard.2020.102324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2020.102324</ArticleId><ArticleId IdType="pmc">PMC7311915</ArticleId><ArticleId IdType="pubmed">32615528</ArticleId></ArticleIdList></Reference><Reference><Citation>Wingerchuk D.M., Banwell B., Bennett J.L., Cabre P., Carroll W., Chitnis T., de Seze J., Fujihara K., Greenberg B., Jacob A., et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85:177&#x2013;189. doi: 10.1212/WNL.0000000000001729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001729</ArticleId><ArticleId IdType="pmc">PMC4515040</ArticleId><ArticleId IdType="pubmed">26092914</ArticleId></ArticleIdList></Reference><Reference><Citation>Hepburn M., Mullaguri N., George P., Hantus S., Punia V., Bhimraj A., Newey C.R. Acute Symptomatic Seizures in Critically Ill Patients with COVID-19: Is There an Association? Neurocrit. Care. 2021;34:139&#x2013;143. doi: 10.1007/s12028-020-01006-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12028-020-01006-1</ArticleId><ArticleId IdType="pmc">PMC7253233</ArticleId><ArticleId IdType="pubmed">32462412</ArticleId></ArticleIdList></Reference><Reference><Citation>Afshar H., Yassin Z., Kalantari S., Aloosh O., Lotfi T., Moghaddasi M., Sadeghipour A., Emamikhah M. Evolution and resolution of brain involvement associated with SARS-CoV-2 infection: A close Clinical&#x2014;Paraclinical follow up study of a case. Mult. Scler. Relat. Disord. 2020;43:102216. doi: 10.1016/j.msard.2020.102216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2020.102216</ArticleId><ArticleId IdType="pmc">PMC7240267</ArticleId><ArticleId IdType="pubmed">32464585</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedetti F., Palladini M., Paolini M., Melloni E., Vai B., De Lorenzo R., Furlan R., Rovere-Querini P., Falini A., Mazza M.G. Brain correlates of depression, post-traumatic distress, and inflammatory biomarkers in COVID-19 survivors: A multimodal magnetic resonance imaging study. Brain Behav. Immun. Health. 2021;18:100387. doi: 10.1016/j.bbih.2021.100387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2021.100387</ArticleId><ArticleId IdType="pmc">PMC8562046</ArticleId><ArticleId IdType="pubmed">34746876</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecchetti G., Agosta F., Canu E., Basaia S., Barbieri A., Cardamone R., Bernasconi M.P., Castelnovo V., Cividini C., Cursi M., et al. Cognitive, EEG, and MRI features of COVID-19 survivors: A 10-month study. J. Neurol. 2022;269:3400&#x2013;3412. doi: 10.1007/s00415-022-11047-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-022-11047-5</ArticleId><ArticleId IdType="pmc">PMC8898558</ArticleId><ArticleId IdType="pubmed">35249144</ArticleId></ArticleIdList></Reference><Reference><Citation>Anzalone N., Castellano A., Scotti R., Scandroglio A.M., Filippi M., Ciceri F., Tresoldi M., Falini A. Multifocal laminar cortical brain lesions: A consistent MRI finding in neuro-COVID-19 patients. J. Neurol. 2020;267:2806&#x2013;2809. doi: 10.1007/s00415-020-09966-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-09966-2</ArticleId><ArticleId IdType="pmc">PMC7275660</ArticleId><ArticleId IdType="pubmed">32506390</ArticleId></ArticleIdList></Reference><Reference><Citation>Naeije R., Caravita S. Phenotyping long COVID. Eur. Respir. J. 2021;58:2101763. doi: 10.1183/13993003.01763-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01763-2021</ArticleId><ArticleId IdType="pmc">PMC8287735</ArticleId><ArticleId IdType="pubmed">34244323</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukiw W.J., Pogue A., Hill J.M. SARS-CoV-2 Infectivity and Neurological Targets in the Brain. Cell Mol. Neurobiol. 2022;42:42,217&#x2013;224. doi: 10.1007/s10571-020-00947-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-020-00947-7</ArticleId><ArticleId IdType="pmc">PMC7445393</ArticleId><ArticleId IdType="pubmed">32840758</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Knight M., A&#x2019;Court C., Buxton M., Husain L. Management of post-acute covid-19 in primary care. The BMJ. 2020;370:m3026. doi: 10.1136/bmj.m3026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: Putative pathophysiology, risk factors, and treatments. Infect. Dis. 2021;53:737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaduganathan M., Vardeny O., Michel T., McMurray J.J.V., Pfeffer M.A., Solomon S.D. Renin-Angiotensin-Aldosterone system inhibitors in patients with COVID-19. N. Engl. J. Med. 2020;382:1653&#x2013;1659. doi: 10.1056/NEJMsr2005760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsr2005760</ArticleId><ArticleId IdType="pmc">PMC7121452</ArticleId><ArticleId IdType="pubmed">32227760</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K.D., Zhao J., Auh S., Yang X., Du P., Tang H., Fu Y.X. Adaptive immune cells temper initial innate responses. Nat. Med. 2007;13:1248&#x2013;1252. doi: 10.1038/nm1633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1633</ArticleId><ArticleId IdType="pmc">PMC2435248</ArticleId><ArticleId IdType="pubmed">17891146</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlsson A.C., Humbert M., Buggert M. The known unknowns of T cell immunity to COVID-19. Sci. Immunol. 2020;8063:5. doi: 10.1126/sciimmunol.abe8063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abe8063</ArticleId><ArticleId IdType="pubmed">33208380</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrenfeld M., Tincani A., Andreoli L., Cattalini M., Greenbaum A., Kanduc D., Alijotas-Reig J., Zinserling V., Semenov N., Howard Amital H., et al. COVID-19 and autoimmunity. Autoimmun. Rev. 2020;19:102597. doi: 10.1016/j.autrev.2020.102597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102597</ArticleId><ArticleId IdType="pmc">PMC7289100</ArticleId><ArticleId IdType="pubmed">32535093</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui D.T.W., Lee C.H., Chow W.S., Lee A.C.H., Tam A.R., Fong C.H.Y., Law C.Y., Leung E.K.H., To K.K.W., Kathryn Choon Beng Tan K.C.B., et al. Thyroid dysfunction in relation to immune profile, disease status and outcome in 191 patients with COVID-19. J. Clin. Endocrinol. Metab. 2021;106:e926&#x2013;e935. doi: 10.1210/clinem/dgaa813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgaa813</ArticleId><ArticleId IdType="pmc">PMC7665541</ArticleId><ArticleId IdType="pubmed">33141191</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller I., Cannavaro D., Dazzi D., Covelli D., Mantovani G., Muscatello A., Ferrante E., Orsi E., Resi V., Longari V., et al. SARS-CoV-2-related atypical thyroiditis. Lancet Diabetes Endocrinol. 2020;8:739&#x2013;741. doi: 10.1016/S2213-8587(20)30266-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(20)30266-7</ArticleId><ArticleId IdType="pmc">PMC7392564</ArticleId><ArticleId IdType="pubmed">32738929</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y., Estes S.K., Ali R.A., Gandhi A.A., Yalavarthi S., Shi H., Sule G., Gockman K., Jacqueline A Madison J.A., Zuo M., et al. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci. Transl. Med. 2020;12:3876. doi: 10.1126/scitranslmed.abd3876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abd3876</ArticleId><ArticleId IdType="pmc">PMC7724273</ArticleId><ArticleId IdType="pubmed">33139519</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P., Rosen L.B., Zhang Q., Michailidis E., Hoffmann H.H., Zhang Y., Dorgham k., Philippot Q., Rosain J., B&#xe9;ziat V., et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;1979:370. doi: 10.1126/science.abd4585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4585</ArticleId><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkon K., Casali P. Nature and functions of autoantibodies. Nat. Clin. Pract. Rheumatol. 2008;4:491&#x2013;498. doi: 10.1038/ncprheum0895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncprheum0895</ArticleId><ArticleId IdType="pmc">PMC2703183</ArticleId><ArticleId IdType="pubmed">18756274</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong M., Zhang H., Cao X., Mao X., Lu Z. Higher level of Neutrophil-to-Lymphocyte is associated with severe COVID-19. Epidemiol. Infect. 2020;148:e139. doi: 10.1017/S0950268820001557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268820001557</ArticleId><ArticleId IdType="pmc">PMC7360950</ArticleId><ArticleId IdType="pubmed">32641174</ArticleId></ArticleIdList></Reference><Reference><Citation>Fathi N., Rezaei N. Lymphopenia in COVID-19: Therapeutic opportunities. Cell Biol. Int. 2020;44:1792&#x2013;1797. doi: 10.1002/cbin.11403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbin.11403</ArticleId><ArticleId IdType="pmc">PMC7283672</ArticleId><ArticleId IdType="pubmed">32458561</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu F., Chen F., Ou Z., Fan O., Tan X., Wang Y., Pan Y., Ke B., Li L., Guan Y., et al. A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract. Cell Mol. Immunol. 2020;17:1119&#x2013;1125. doi: 10.1038/s41423-020-00550-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-00550-2</ArticleId><ArticleId IdType="pmc">PMC7546387</ArticleId><ArticleId IdType="pubmed">33037400</ArticleId></ArticleIdList></Reference><Reference><Citation>Amato M.K., Hennessy C., Shah K., Mayer J. Multisystem inflammatory syndrome in an adult. J. Emerg. Med. 2021;61:e1&#x2013;e3. doi: 10.1016/j.jemermed.2021.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jemermed.2021.02.007</ArticleId><ArticleId IdType="pmc">PMC8026263</ArticleId><ArticleId IdType="pubmed">33838966</ArticleId></ArticleIdList></Reference><Reference><Citation>Love C., Tomas M.B., Bronco G.G., Palestro C.J. FDG PET of infection and inflammation. Radiographics. 2005;25:1357&#x2013;1368. doi: 10.1148/rg.255045122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/rg.255045122</ArticleId><ArticleId IdType="pubmed">16160116</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollini M., Ciccarelli M., Cecconi M., Aghemo A., Morelli P., Gelardi F., Chiti A. Vasculitis changes in COVID-19 survivors with persistent symptoms: An [18 F] FDG-PET/CT study. Eur. J. Nucl. Med. Mol. Imaging. 2020;48:1460&#x2013;1466. doi: 10.1007/s00259-020-05084-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-020-05084-3</ArticleId><ArticleId IdType="pmc">PMC7595761</ArticleId><ArticleId IdType="pubmed">33123760</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucuk A., Cumhur C.M., Cure E. Can COVID-19 cause myalgia with a completely different mechanism? A hypothesis. Clin. Rheumatol. 2020;39:2103&#x2013;2104. doi: 10.1007/s10067-020-05178-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-020-05178-1</ArticleId><ArticleId IdType="pmc">PMC7249985</ArticleId><ArticleId IdType="pubmed">32458242</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895.e20. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Congqing Wu C., Wei Lu W., Zhang Y., Guoying Zhang G., Shi X., Hisada Y., Grover S.P., Xinyi Zhang X., Li L., Xiang B., et al. Inflammasome activation triggers blood clotting and host death through pyroptosis. Immunity. 2019;50:1401&#x2013;1411.e4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6791531</ArticleId><ArticleId IdType="pubmed">31076358</ArticleId></ArticleIdList></Reference><Reference><Citation>Bochenek M.L., Sch&#xe4;fer K. Role of endothelial cells in acute and chronic thrombosis. Hamostaseologie. 2019;39:128&#x2013;139. doi: 10.1055/s-0038-1675614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0038-1675614</ArticleId><ArticleId IdType="pubmed">30620989</ArticleId></ArticleIdList></Reference><Reference><Citation>Rauch U., Nemerson Y. Tissue Factor, the Blood, and the Arterial Wall. Trends. Cardiovasc. Med. 2000;10:139&#x2013;143. doi: 10.1016/S1050-1738(00)00049-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1050-1738(00)00049-9</ArticleId><ArticleId IdType="pubmed">11239792</ArticleId></ArticleIdList></Reference><Reference><Citation>Hottz E.D., Azevedo-Quintanilha I.G., Palhinha L., Teixeira L., Barreto E.A., P&#xe3;o C.R., Righy C., Franco S., Souza T.M., Pedro Kurtz P., et al. Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19. Blood. 2020;136:1330&#x2013;1341. doi: 10.1182/blood.2020007252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020007252</ArticleId><ArticleId IdType="pmc">PMC7483437</ArticleId><ArticleId IdType="pubmed">32678428</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Ani F., Chehade S., Lazo-Langner A. Thrombosis risk associated with COVID-19 infection. A scoping review. Thromb. Res. 2020;192:152&#x2013;160. doi: 10.1016/j.thromres.2020.05.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.05.039</ArticleId><ArticleId IdType="pmc">PMC7255332</ArticleId><ArticleId IdType="pubmed">32485418</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F., Perego E. How and why patients made Long Covid. Soc. Sci. Med. 2021;268:113426. doi: 10.1016/j.socscimed.2020.113426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmann D.M., Boyton R.J. Decoding the unknowns in long covid. The BMJ. 2021;372:n132. doi: 10.1136/bmj.n132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n132</ArticleId><ArticleId IdType="pubmed">33541867</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. NICE guideline on long COVID. Lancet Respir. Med. 2021;9:129. doi: 10.1016/S2213-2600(21)00031-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00031-X</ArticleId><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>Nath A. Long-Haul COVID. Neurology. 2020;95:559&#x2013;560. doi: 10.1212/WNL.0000000000010640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010640</ArticleId><ArticleId IdType="pubmed">32788251</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P. Immune determinants of COVID-19 disease presentation and severity. Nat. Med. 2021;27:28&#x2013;33. doi: 10.1038/s41591-020-01202-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-01202-8</ArticleId><ArticleId IdType="pubmed">33442016</ArticleId></ArticleIdList></Reference><Reference><Citation>Davido B., Seang S., Tubiana R., de Truchis P. Post&#x2013;COVID-19 chronic symptoms: A postinfectious entity? Clin. Microbiol. Infect. 2020;26:1448&#x2013;1449. doi: 10.1016/j.cmi.2020.07.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.07.028</ArticleId><ArticleId IdType="pmc">PMC7376333</ArticleId><ArticleId IdType="pubmed">32712242</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta S.D., Talwar A., Lee J.T. A Proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 Infection: Illness beyond acute infection and public health implications. JAMA J. Am. Med. Assoc. 2020;324:2251&#x2013;2252. doi: 10.1001/jama.2020.22717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.22717</ArticleId><ArticleId IdType="pubmed">33206133</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M., Taylor S. NICE guideline on long COVID: Research must be done urgently to fill the many gaps in this new &#x2018;living guideline&#x2019;. BMJ. 2020;371:m4938. doi: 10.1136/bmj.m4938.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m4938</ArticleId><ArticleId IdType="pubmed">33361141</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-De-las-pe&#xf1;as C., Palacios-Ce&#xf1;a D., G&#xf3;mez-Mayordomo V., Cuadrado M.L., Florencio L.L. Defining post-covid symptoms (Post-acute covid, long covid, persistent post-covid): An integrative classification. Int. J. Environ. Res. Public Health. 2021;18:2621. doi: 10.3390/ijerph18052621.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18052621</ArticleId><ArticleId IdType="pmc">PMC7967389</ArticleId><ArticleId IdType="pubmed">33807869</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W., Hillman T., Playford E.D., Hishmeh L. Managing the long-term effects of COVID-19: Summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:n136. doi: 10.1136/bmj.n136. Erratum in BMJ 2022, 376, o126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcionivoschi N., Drinceanu D., Stef L., Luca I., Julean C. Probiotics-identification and ways of action. Innov. Rom. Food Biotechnol. 2010;6:1.</Citation></Reference><Reference><Citation>Gibson G.R., Hutkins R., Sanders M.E., Prescott S.L., Reimer R.A., Salminen S.J., Scott K., Stanton C., Swanson K.S., Cani P.D., et al. Expert consensus document: The International scientific association for probiotics and prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat. Rev. Gastroenterol. Hepatol. 2017;14:491&#x2013;502. doi: 10.1038/nrgastro.2017.75.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrgastro.2017.75</ArticleId><ArticleId IdType="pubmed">28611480</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J., Zhang L., Lin W., Tang W., Chan F.K., Ng S.C. Review article: Probiotics, prebiotics and dietary approaches during COVID-19 pandemic. Trends Food Sci. Technol. 2021;108:187&#x2013;196. doi: 10.1016/j.tifs.2020.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tifs.2020.12.009</ArticleId><ArticleId IdType="pmc">PMC7833886</ArticleId><ArticleId IdType="pubmed">33519087</ArticleId></ArticleIdList></Reference><Reference><Citation>Baud D., Agri V.D., Gibson G.R., Reid G., Giannoni E. Using probiotics to flatten the curve of coronavirus disease COVID-2019 Pandemic. Front. Public Health. 2020;8:186. doi: 10.3389/fpubh.2020.00186.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.00186</ArticleId><ArticleId IdType="pmc">PMC7227397</ArticleId><ArticleId IdType="pubmed">32574290</ArticleId></ArticleIdList></Reference><Reference><Citation>Olaimat A.N., Aolymat I., Al-Holy M., Ayyash M., Abu Ghoush M., Al-Nabulsi A.A., Osaili T., Apostolopoulos V., Liu S.Q., Shah N.P. The potential application of probiotics and prebiotics for the prevention and treatment of COVID-19. NPJ Sci. Food. 2020;4:1&#x2013;7. doi: 10.1038/s41538-020-00078-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41538-020-00078-9</ArticleId><ArticleId IdType="pmc">PMC7536434</ArticleId><ArticleId IdType="pubmed">33083549</ArticleId></ArticleIdList></Reference><Reference><Citation>Batista K.S., de Albuquerque J.G., Vasconcelos M., Bezerra M., da Silva Barbalho M.B., Pinheiro R.O., Aquino J.S. Probiotics and prebiotics: Potential prevention and therapeutic target for nutritional management of COVID-19? Nutr. Res. Rev. 2021:1&#x2013;18. doi: 10.1017/S0954422421000317. Epub ahead of print.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0954422421000317</ArticleId><ArticleId IdType="pmc">PMC8593414</ArticleId><ArticleId IdType="pubmed">34668465</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D., Li S., Wang N., Tan H.Y., Zhang Z., Feng Y. The Crosstalk between gut microbiota and lungs in common lung diseases. Front. Microbiol. 2020;11:301. doi: 10.3389/fmicb.2020.00301.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.00301</ArticleId><ArticleId IdType="pmc">PMC7052046</ArticleId><ArticleId IdType="pubmed">32158441</ArticleId></ArticleIdList></Reference><Reference><Citation>National Health Committee of the People&#x2019;s Republic of China  National Administration of Traditional Chinese Medicine Diagnostic and Therapeutic Guidance for 2019 Novel Coronavirus Disease (Version 5)  [(accessed on 5 June 2022)];2019  Available online:  http://www.nhc.gov.cn/yzygj/s7653p/202002/d4b895337e19445f8d728fcaf1e3e13a/files/ab6bec7f93e64e7f998d802991203cd6.pdf.</Citation></Reference><Reference><Citation>Liang Y., Liang S., Zhang Y., Deng Y., He Y., Chen Y., Liu C., Lin C., Yang Q. Oral administration of compound probiotics ameliorates HFD-Induced gut microbe dysbiosis and chronic metabolic inflammation via the G Protein-Coupled Receptor 43 in Non-alcoholic fatty liver disease rats. Probiotics Antimicrob Proteins. 2019;11:175&#x2013;185. doi: 10.1007/s12602-017-9378-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12602-017-9378-3</ArticleId><ArticleId IdType="pubmed">29353414</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao S., Feng P., Meng W., Jin W., Li X., Li X. Modulated gut microbiota for potential COVID-19 prevention and treatment. Front. Med. 2022;9:811176. doi: 10.3389/fmed.2022.811176.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.811176</ArticleId><ArticleId IdType="pmc">PMC8927624</ArticleId><ArticleId IdType="pubmed">35308540</ArticleId></ArticleIdList></Reference><Reference><Citation>Klaenhammer T.R., Kleerebezem M., Kopp M.V., Rescigno M. The impact of probiotics and prebiotics on the immune system. Nat. Rev. Immunol. 2012;12:728&#x2013;734. doi: 10.1038/nri3312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3312</ArticleId><ArticleId IdType="pubmed">23007572</ArticleId></ArticleIdList></Reference><Reference><Citation>Ettinger G., MacDonald K., Reid G., Burton J.P. The influence of the human microbiome and probiotics on cardiovascular health. Gut Microbes. 2015;5:719&#x2013;728. doi: 10.4161/19490976.2014.983775.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/19490976.2014.983775</ArticleId><ArticleId IdType="pmc">PMC4615746</ArticleId><ArticleId IdType="pubmed">25529048</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., Cheng F., Xu Q., Su Y., Cai X., Zeng F., Zhang Y. The role of probiotics in coronavirus disease-19 infection in Wuhan: A retrospective study of 311 severe patients. Int. Immunopharmacol. 2021;95:107531. doi: 10.1016/j.intimp.2021.107531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.107531</ArticleId><ArticleId IdType="pmc">PMC7934664</ArticleId><ArticleId IdType="pubmed">33714884</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliva S., Di Nardo G., Ferrari F., Mallardo S., Rossi P., Patrizi G., Cucchiara S., Stronati L. Randomised clinical trial: The effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis. Aliment. Pharmacol. Ther. 2012;35:327&#x2013;334. doi: 10.1111/j.1365-2036.2011.04939.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2036.2011.04939.x</ArticleId><ArticleId IdType="pubmed">22150569</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu K., Cai H., Shen Y., Ni Q., Chen Y., Hu S., Li J., Wang H., Yu L., Huang H., et al. Management of COVID-19: The Zhejiang experience the: Zhejiang experience. J. Zhejiang University. Med. Sci. 2020;49:147&#x2013;157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8800711</ArticleId><ArticleId IdType="pubmed">32391658</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhar D., Mohanty A. Gut microbiota and COVID-19- possible link and implications. Virus Res. 2020;285:198018. doi: 10.1016/j.virusres.2020.198018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2020.198018</ArticleId><ArticleId IdType="pmc">PMC7217790</ArticleId><ArticleId IdType="pubmed">32430279</ArticleId></ArticleIdList></Reference><Reference><Citation>Gogineni V.K., Morrow L.E., Malesker M.A. Probiotics: Mechanisms of action and clinical applications. J. Probiotics Health. 2013;1:1&#x2013;11. doi: 10.4172/2329-8901.1000101.</Citation><ArticleIdList><ArticleId IdType="doi">10.4172/2329-8901.1000101</ArticleId></ArticleIdList></Reference><Reference><Citation>Amer M., Nadeem M., Nazir S., Fakhar M., Abid F., Ain Q.U., Asif E. Probiotics and their use in inflammatory bowel disease. Altern. Ther. Health Med. 2018;24:16&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">29135456</ArticleId></ArticleIdList></Reference><Reference><Citation>Davani-Davari D., Negahdaripour M., Karimzadeh I., Seifan M., Mohkam M., Masoumi S.J., Berenjian A., Ghasemi Y. Prebiotics: Definition, types, sources, mechanisms, and clinical applications. Foods. 2019;92:8. doi: 10.3390/foods8030092.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/foods8030092</ArticleId><ArticleId IdType="pmc">PMC6463098</ArticleId><ArticleId IdType="pubmed">30857316</ArticleId></ArticleIdList></Reference><Reference><Citation>Parnell J.A., Reimer R.A. Prebiotic fiber modulation of the gut microbiota improves risk factors for obesity and the metabolic syndrome. Gut Microbes. 2012;3:29&#x2013;34. doi: 10.4161/gmic.19246.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/gmic.19246</ArticleId><ArticleId IdType="pmc">PMC3827018</ArticleId><ArticleId IdType="pubmed">22555633</ArticleId></ArticleIdList></Reference><Reference><Citation>Wici&#x144;ski M., G&#x119;balski J., Mazurek E., Podhorecka M., &#x15a;niegocki M., Szychta P., Sawicka E., Malinowski B. The influence of polyphenol compounds on human gastrointestinal tract microbiota. Nutrients. 2020;350:12. doi: 10.3390/nu12020350.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12020350</ArticleId><ArticleId IdType="pmc">PMC7071305</ArticleId><ArticleId IdType="pubmed">32013109</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranucci G., Buccigrossi V., Borgia E., Piacentini D., Visentin F., Cantarutti L., Baiardi P., Felisi M., Spagnuolo M.I., Zanconato S., et al. Galacto-oligosaccharide/polidextrose enriched formula protects against respiratory infections in infants at high risk of atopy: A randomized clinical trial. Nutrients. 2018;10:286. doi: 10.3390/nu10030286.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu10030286</ArticleId><ArticleId IdType="pmc">PMC5872704</ArticleId><ArticleId IdType="pubmed">29494489</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Xiao Y., Tian F., Zhao J., Zhang H., Zhai Q., Chen W. Rational use of prebiotics for gut microbiota alterations: Specific bacterial phylotypes and related mechanisms. J. Funct. Foods. 2020;66:103838. doi: 10.1016/j.jff.2020.103838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jff.2020.103838</ArticleId></ArticleIdList></Reference><Reference><Citation>West C.E., Dzidic M., Prescott S.L., Jenmalm M.C. Bugging allergy; role of pre-, pro- and synbiotics in allergy prevention. Allergol. Int. 2017;66:529&#x2013;538. doi: 10.1016/j.alit.2017.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.alit.2017.08.001</ArticleId><ArticleId IdType="pubmed">28865967</ArticleId></ArticleIdList></Reference><Reference><Citation>Din A.U., Mazhar M., Waseem M., Ahmad W., Bibi A., Hassan A., Ali N., Gang W., Qian G., Ullah R., et al. SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role. Biomed. Pharmacother. 2021;133:110947. doi: 10.1016/j.biopha.2020.110947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.110947</ArticleId><ArticleId IdType="pmc">PMC7657099</ArticleId><ArticleId IdType="pubmed">33197765</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>